US court overturns GSK drug patent verdict to rule in Teva's favour

A federal judge on Wednesday overturned a US jury’s verdict that required Teva Pharmaceutical to pay GlaxoSmithKline more than $235m (£167m) for infringing a patent covering its blood pressure drug Coreg.

https://bit.ly/2IbOwE2